Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:14 PM
Ignite Modification Date:
2025-12-24 @ 3:14 PM
NCT ID:
NCT03901092
Eligibility Criteria:
Scan Reader Criteria (5 total):
* Board-certified in radiology or nuclear medicine
* Professional experience interpreting PET scans
* Naive to study protocol
* No previous training or exposure to Avid Flortaucipir F 18 read methodology
Scan Criteria:
\- Previous enrollment in Study A05 confirmatory cohort (NCT02016560), or A16 (NCT02516046)
Scan Study Population Criteria for FR01 (A05 confirmatory cohort):
* Cognitively-impaired
* mild cognitive impairment (MCI) or dementia with suspected neurodegenerative cause
* mini-mental status exam (MMSE) score of 20-27, inclusive
Scan Study Population Criteria for FR01 (Study A16):
* Subjects at end of life (less than or equal to 6 months)
* Imaged with flortaucipir F18 and came to autopsy
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03901092
Study Brief:
Protocol Section:
NCT03901092